Bayer AG

Pfizer bets on gene therapy as technology comes of age

Pfizer Inc is moving into the gene therapy space in the latest sign that the technology for fixing faulty genes may finally be ready for prime time, following earlier setbacks.

Read Full Article

Drug majors Novartis, Merck in talks to trade business units

Pharma giants Novartis International AG and Merck & Co. Inc. are reportedly negotiating an asset trade of about $5 billion each. Novartis wants to exchange its animal health and human vaccines businesses for Merck's over-the-counter health products unit.

Read Full Article

Bayer in negotiations regarding USD2.4 billion acquisition of partner Algeta

Despite the offer at a 27% premium from yesterday's trading close of Algeta ASA's shares, the Norwegian company said through a spokesperson that it does not guarantee that it will accept Bayer AG's offer.

Read Full Article

Bayer AG Purchases Conceptus

Bayer AG purchases US contraceptive maker Conceptus.

Read Full Article

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics